Azacitidine Injection Shortage: Supply Updates and Manufacturer Availability
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Azacitidine Injection, an oncology medication, is currently experiencing supply challenges with mixed availability across several major manufacturers.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on February 11, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — Drug Shortages — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA drug-shortage notice is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (drug-shortage, fda, medication, Azacitidine) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What's in Shortage
Azacitidine Injection (Brand name: AZACITIDINE) is currently listed in the FDA database as being in shortage. This medication is used in oncology and is supplied as an injection. The shortage specifically affects the 100 mg dosage forms. This shortage was initially posted on December 18, 2020, and was most recently updated on February 10, 2026.
Which Manufacturers Are Affected
Supply levels vary significantly across the five manufacturers currently listed:
- Accord Healthcare Inc.: Available. (100 mg, NDC 16729-306-10). Contact: 866-941-7875, option 2.
- Dr. Reddy's Laboratories, Inc.: Available, but limited to existing customers. (100 mg, NDC 43598-305-62). Contact: 866-732-3952.
- Fresenius Kabi USA, LLC: Available; providers are encouraged to check wholesaler inventory. (100 mg/30 mL, NDC 63323-771-39). Contact: 1-888-386-1300.
- Eugia US LLC: Currently unavailable and on backorder. Recovery date is to be determined (TBD). (100 mg/4 mL, NDC 55150-393-01). Contact: 888-238-7880.
- Teva Pharmaceuticals USA, Inc.: Currently unavailable. Estimated availability is to be determined (TBD). (100 mg, NDC 68001-313-56). Contact: 800-545-8800.
Why There's a Shortage
The FDA source data does not provide a specific reason for the current supply limitations of Azacitidine Injection.
What Patients Should Do
Patients who rely on this medication should take the following practical steps:
- Consult Your Healthcare Provider: Discuss your treatment schedule with your oncologist or doctor to ensure continuity of care.
- Speak with Your Pharmacist: Ask about current inventory levels and if they can secure supply from the manufacturers that currently have the drug available.
- Contact Manufacturers: If necessary, use the contact numbers provided above to inquire about the most recent availability updates for specific product presentations.
Disclaimer: Patients should always consult their healthcare provider regarding medical advice, dosing, and treatment alternatives.
Source
Information sourced from the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.
What is this FDA drug-shortage notice about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more Drug Shortages updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category